Portfolio company
Carthera
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an ultrasound-based medical device to increase the permeability of the blood-brain barrier for patients with tumours and neurodegenerative diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cordance Medical
This company develops a focused ultrasound device to open the blood-brain barrier for clinicians treating patients with brain tumours and other neurological diseases.
Brain-to-Computer Interface
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
EnClear Therapies
The company develops a drug delivery system for the cerebrospinal fluid to treat patients with neurological diseases and brain tumours.
Attune Neurosciences
This company develops wearable ultrasound neurostimulation devices for patients and government agencies to treat brain disorders and improve cognitive performance.
QV Bioelectronics
The company develops implantable bioelectronic devices that deliver electric field therapy to treat patients with aggressive brain tumours.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
Curix
Curix develops a microbubble injection platform and focused ultrasound technology for non-invasive drug delivery across the blood-brain barrier for patients with neurological diseases.
Neuroharmonics
This company develops non-invasive ultrasound devices to modulate deep brain circuits for patients with movement disorders, depression, chronic pain, and addiction.
